UNSPSC 51201606: Hemophilus influenzae vaccine

This classification denotes a vaccine for a species of haemophilus found on the mucous membranes of humans and a variety of animals, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2495X8VZXG.

UNSPSC 51201606 Hemophilus influenzae vaccine is a Commodity code, but the most recent state and local opportunity posted under it does not reflect purchase activity aligned with the code's nominal scope. The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026, for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 — a product outside the hemophilus influenzae vaccine category. The notice invites any person or entity to challenge the sole source designation by submitting written objections with detailed explanation and supporting documentation demonstrating that another vendor can supply the vaccine; if substantiated objections are received showing alternative sources exist, the department will withdraw the sole source notice and conduct a competitive bid or selection process, or appeal to the Public Procurement Review Board if it determines only Sanofi Pasteur can supply the product. The notice does not specify quantity, contract term, estimated value, or pricing.

The code shows insufficient recent activity to characterize a meaningful pattern of state and local procurement under its actual scope. The single posted opportunity is a misclassified sole source notice for a different vaccine product, not a competitive solicitation for hemophilus influenzae vaccine. Business development professionals monitoring this code should note the mismatch and watch for future solicitations that align with the code's intended commodity category.